2-chlorobenzyl chloride has been researched along with Myasthenia Gravis in 2 studies
*Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ALAJOUANINE, T; BOURGUIGNON, A; CAMBIER, J; CASTAIGNE, P | 1 |
| MARSHALL, CK; SCHWAB, RS; TIMBERLAKE, W | 1 |
2 other study(ies) available for 2-chlorobenzyl chloride and Myasthenia Gravis
| Article | Year |
|---|---|
[Clinical trials with a new anti-myasthenic drug: N, N'-bis (2-diethylaminoethyl)-oxamide bis-2-chlorobenzyl chloride (Win 8077)].
Topics: Benzyl Compounds; Chlorides; Myasthenia Gravis; Oxamic Acid; Parasympathomimetics | 1958 |
WIN 8077 in treatment of myasthenia gravis; use of N,N'-bis (2-diethylaminoethyl) oxamide bis-2-chlorobenzyl chloride in fifty patients.
Topics: Ambenonium Chloride; Benzyl Compounds; Ions; Myasthenia Gravis; Oxamic Acid; Parasympathomimetics | 1955 |